propionylcarnitine has been researched along with Scleroderma, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cauli, A; Iliceto, S; Lai, S; Mathieu, A; Meloni, L; Montisci, M; Montisci, R; Passiu, G; Ruscazio, M; Vacca, A | 1 |
1 trial(s) available for propionylcarnitine and Scleroderma, Systemic
| Article | Year |
|---|---|
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
Topics: Adenosine; Adult; Aged; Blood Flow Velocity; Cardiotonic Agents; Cardiovascular Diseases; Carnitine; Coronary Circulation; Coronary Vessels; Echocardiography, Doppler; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Myocardium; Pilot Projects; Scleroderma, Systemic | 2007 |